title: Cervical dysplasia in immunosuppressed IBD women.
authors.forename: Yamile
authors.initials: Y
authors.lastname: Zabana
authors.forename: Manuel
authors.initials: M
authors.lastname: Barreiro
authors.forename: Míriam
authors.initials: M
authors.lastname: Mañosa
authors.forename: Aurelio
authors.initials: A
authors.lastname: Lorenzo
authors.forename: Eduard
authors.initials: E
authors.lastname: Cabré
authors.forename: Eugeni
authors.initials: E
authors.lastname: Domènech
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000276:immunology; D053918:Papillomavirus Vaccines / Q000276:immunology / Q000627:therapeutic use; D013030:Spain; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D002583:Uterine Cervical Neoplasms / Q000276:immunology; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents; D053918:Papillomavirus Vaccines